A detailed history of Woodline Partners LP transactions in Alkermes Plc. stock. As of the latest transaction made, Woodline Partners LP holds 741,680 shares of ALKS stock, worth $21.9 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
741,680
Previous 1,071,071 30.75%
Holding current value
$21.9 Million
Previous $25.8 Million 19.58%
% of portfolio
0.19%
Previous 0.26%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$23.01 - $28.55 $7.58 Million - $9.4 Million
-329,391 Reduced 30.75%
741,680 $20.8 Million
Q2 2024

Aug 14, 2024

BUY
$23.21 - $27.24 $28,571 - $33,532
1,231 Added 0.12%
1,071,071 $25.8 Million
Q1 2024

May 15, 2024

SELL
$26.4 - $32.56 $2.66 Million - $3.28 Million
-100,849 Reduced 8.61%
1,069,840 $29 Million
Q3 2023

Nov 14, 2023

BUY
$27.17 - $31.97 $31.8 Million - $37.4 Million
1,170,689 New
1,170,689 $32.8 Million
Q2 2022

Aug 15, 2022

BUY
$26.4 - $30.54 $14.3 Million - $16.6 Million
542,441 Added 41.27%
1,856,847 $55.3 Million
Q1 2022

May 16, 2022

SELL
$23.07 - $27.99 $7.02 Million - $8.52 Million
-304,399 Reduced 18.8%
1,314,406 $34.6 Million
Q4 2021

Feb 14, 2022

BUY
$21.47 - $32.08 $13.3 Million - $19.9 Million
620,848 Added 62.21%
1,618,805 $37.7 Million
Q3 2021

Nov 15, 2021

BUY
$23.37 - $32.13 $163 - $224
7 Added 0.0%
997,957 $30.8 Million
Q2 2021

Aug 16, 2021

BUY
$18.78 - $25.15 $2.37 Million - $3.18 Million
126,390 Added 14.5%
997,950 $24.5 Million
Q1 2021

May 17, 2021

SELL
$18.21 - $23.2 $23.1 Million - $29.5 Million
-1,269,809 Reduced 59.3%
871,560 $16.3 Million
Q4 2020

Feb 16, 2021

SELL
$15.39 - $22.1 $5.47 Million - $7.86 Million
-355,450 Reduced 14.24%
2,141,369 $42.7 Million
Q3 2020

Nov 16, 2020

BUY
$16.16 - $20.66 $10.5 Million - $13.4 Million
648,277 Added 35.07%
2,496,819 $41.4 Million
Q2 2020

Aug 14, 2020

BUY
$13.31 - $19.41 $24.6 Million - $35.9 Million
1,848,542 New
1,848,542 $35.9 Million

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.84B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.